In May the Global AMR R&D Hub called for tenders for the implementation of a study to determine the global market potentials for four prioritised products relevant for addressing AMR. The call closed on June 19, 2020.
26.06.2026
Brussels Discussions Advance Europe’s Antibiotic Innovation Agenda
The Global AMR R&D Hub contributed to two high-level discussions in Brussels on strengthening Europe’s antibiotic innovation ecosystem, with Deputy Director Dr. Ralf Sudbrak and Suzanne Edwards sharing evidence and expertise on investment, pull incentives, and the future of antibiotic R&D.
